What is BPC-157?

BPC-157, or Body Protection Compound-157, is a synthetic pentadecapeptide — a chain of 15 amino acids — derived from a protective protein found in human gastric juice. Its CAS number is 1628202-19-6, and it is supplied as a lyophilized powder for research use. The compound has generated significant interest in preclinical research since the early 1990s, primarily for its observed effects in tissue repair and cytoprotection models.

It is important to note upfront: BPC-157 is not approved by the FDA or any regulatory body for human use. All data referenced in this article comes from in vitro and animal studies. No human clinical trials have been completed to date.

Mechanism of Action

BPC-157’s mechanism remains a subject of active research, but several pathways have been consistently observed across published studies.

Nitric Oxide System Modulation

Multiple studies have demonstrated that BPC-157 interacts with the nitric oxide (NO) system. In rodent models, BPC-157 appears to modulate NO synthase activity, influencing vascular tone and blood flow to damaged tissues. This interaction has been observed in models of both NO-depleted and NO-excess states, suggesting a modulatory rather than purely stimulatory role.

Growth Factor Upregulation

Preclinical evidence suggests BPC-157 may upregulate several growth factors relevant to tissue repair, including vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), and hepatocyte growth factor (HGF). In tendon and ligament injury models in rats, increased expression of these markers has been correlated with accelerated healing timelines compared to untreated controls.

Documented Research Applications

Gastrointestinal Models

The most extensively studied application of BPC-157 is in gastrointestinal research. Studies in rodent models have examined its effects on gastric ulcers (both NSAID-induced and stress-induced), inflammatory bowel disease models, esophageal damage, and intestinal anastomosis healing. The compound’s origin in gastric juice has made GI research a natural area of investigation.

Musculoskeletal Repair Models

A substantial body of preclinical work has examined BPC-157 in tendon, ligament, muscle, and bone healing models. Achilles tendon transection models in rats have shown accelerated tendon-to-bone healing with BPC-157 treatment compared to saline controls. Similar patterns have been observed in quadriceps muscle crush injury models and ligament repair studies.

Neuroprotective Models

More recent research has explored BPC-157 in central and peripheral nervous system injury models, including traumatic brain injury, spinal cord injury, and peripheral nerve transection. While this body of work is smaller than the GI and musculoskeletal literature, published results have shown functional recovery improvements in treated groups versus controls.

What the Literature Supports — and What It Doesn’t

The preclinical evidence for BPC-157 is genuinely extensive — over 100 published studies spanning three decades. However, several important caveats apply.

First, nearly all published research is preclinical. Rodent models dominate the literature, and there is a notable absence of completed human clinical trials. This gap between preclinical promise and clinical validation is significant and should not be glossed over.

Second, much of the published work comes from a relatively small number of research groups, particularly from the University of Zagreb. While the quality of individual studies varies, the concentration of authorship is worth noting from a reproducibility standpoint.

Third, the dose-response relationship in animal studies does not translate directly to any human context. Extrapolating rodent dosages to human-equivalent doses is a common error in non-scientific discussions of BPC-157.

Handling and Storage

BPC-157 is supplied as a lyophilized (freeze-dried) powder. It should be stored at -20°C in a desiccated environment prior to reconstitution. Once reconstituted in bacteriostatic water or sterile saline, aliquots should be stored at 4°C and used within a reasonable timeframe to minimize degradation. As with all peptides, avoid repeated freeze-thaw cycles.

Specifications at a Glance

CAS Number: 1628202-19-6. Molecular Formula: C₆₂H₉₈N₁₆O₂₂. Form: Lyophilized powder. Purity: ≥98% (HPLC). Storage: -20°C.

All BPC-157 supplied by Vial & Error Labs ships with a lot-specific Certificate of Analysis and GHS-compliant Safety Data Sheet. For research use only — not for human or veterinary consumption.